Your search for oral corticosteroids returned 88 results

Pediatric allergic contact dermatitis (ACD) to methylisothiazolinone (MI) may be increasing and should be considered in cases with a history of wet wipe use.

The updated labeling is based on results from a safety management cohort from the ZUMA-1 study.

The patients began treatment with oral sirolimus; after 1 year of treatment, there was improvement in exertional dyspnea in all 3 patients.

Approaches for management of gout are presented in a two-part guideline.

Santarus announced pooled data from two Phase 3 studies of Uceris (budesonide MMX) for the induction of remission of mild or moderate active ulcerative colitis.

For women threatened with preterm labor, maintenance tocolysis with nifedipine is not associated with a significant reduction in adverse perinatal outcomes.

Rilzabrutinib is an oral Bruton tyrosine kinase inhibitor currently in development for a number of immune-mediated diseases.

Study authors evaluated the impact on compliance and SNOT-20 scores in patients with allergic rhinitis using a novel sinus nasal rinse device.

The FDA has approved Zeposia® (ozanimod) for moderately to severely active ulcerative colitis in adults.

Ascorbic acid level testing confirmed severe deficiency (<0.1mg/dL).